R&D Systems™ Recombinant Human CTRP9/C1qTNF9 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human CTRP9/C1qTNF9 Protein is derived from NS0. The Recombinant Human CTRP9/C1qTNF9 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: AAH40438
• Formulation: Lyophilized from a 0.2μm filtered solution in HEPES and NaCl
• Gene ID (Entrez): 338872
• Molecular Weight (g/mol): 34kDa
• Name: C1qTNF9
• Preparation Method: Reconstitute at 250μg/mL in sterile PBS.
• Quality Control Testing: SDS-PAGE: 36-40kDa, reducing conditions
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human CTRP9/C1qTNF9 protein Asn16-Pro333,with an N-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: His
• Without Additives: Carrier Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE with silver staining